HTG Molecular Diagnostics, Inc.
HTGMQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,594 | -$17,145 | -$20,870 | -$19,298 |
| Dep. & Amort. | $587 | $721 | $1,347 | $1,259 |
| Deferred Tax | $0 | $0 | $681 | $0 |
| Stock-Based Comp. | $815 | $1,375 | $1,812 | $1,223 |
| Change in WC | -$143 | -$990 | -$157 | -$486 |
| Other Non-Cash | $1,928 | -$470 | $896 | $605 |
| Operating Cash Flow | -$18,408 | -$16,509 | -$16,292 | -$16,696 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$23 | -$644 | -$454 | -$1,103 |
| Net Acquisitions | $0 | $6 | -$19 | $2 |
| Inv. Purchases | -$7,611 | -$18,620 | -$12,465 | -$34,601 |
| Inv. Sales/Matur. | $19,950 | $12,600 | $31,650 | $32,200 |
| Other Inv. Act. | $104 | -$6 | $19 | -$2 |
| Investing Cash Flow | $12,420 | -$6,665 | $18,731 | -$3,504 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$6,949 | -$766 | $667 | -$44 |
| Stock Issued | $9,018 | $10,666 | $7,546 | $20,759 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $15,554 | $492 | $836 | -$1,323 |
| Financing Cash Flow | $8,605 | $10,392 | $9,049 | $19,392 |
| Forex Effect | -$6 | -$16 | $20 | -$4 |
| Net Chg. in Cash | $2,611 | -$12,798 | $11,508 | -$813 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,600 | $22,398 | $10,890 | $11,703 |
| End Cash | $12,211 | $9,600 | $22,398 | $10,890 |
| Free Cash Flow | -$18,431 | -$17,153 | -$16,746 | -$17,799 |